2020, Number 2
<< Back Next >>
Rev Cub Oftal 2020; 33 (2)
Ophthalmology in the time of COVID-19
Castillo VC, Molinet VL, Pérez PAI, Sablón GR
Language: Spanish
References: 19
Page: 1-14
PDF size: 420.22 Kb.
ABSTRACT
The history of pandemics and modern man have marked a before and after in current medicine, as was the case with the Spanish flu in 1918. The last pandemic recorded worldwide is coronavirus, identified as COVID-19, caused by the viral agent SARS-CoV-2. From its onset on 30 December 2019 this disease has had a close connection to ophthalmology. The purpose of the study was to document the new scientific evidence about this condition and its ocular manifestation through a literature review covering the period extending from 1 January to 25 April 2020, using search terms in English and Spanish. Respiratory symptoms are among the transmission routes most commonly dealt with. However, some ocular manifestations are characterized by the presence of the SARS-CoV-2 virus in tears and in the conjunctiva of patients infected with COVID-19. The most typical manifestation is nonspecific viral conjunctivitis. Mortality rate is a topic of special relevance. The statistics accumulated suggest greater fatality and thus the need to implement social measures and actions aimed at population control. The current fatality rate is 7.2% worldwide, 5.8% in Latin America and 4.2% in Cuba. The present paper provides a comprehensive analysis of COVID-19 based on international recommendations for ophthalmology personnel and facilities, as well as the risk factors, clinical status, new treatments and reports about ongoing clinical studies.
REFERENCES
Olivares-de Emparan JP, Garza-León M, García Aguirre G, Azcárate-Coral T, Penniecook JA, Lansingh VC, et al. Recomendaciones para el manejo de pacientes que requieren atención oftalmológica durante la pandemia de SARS-CoV-2. Rev Mex Oftalmol. 2020;94:2.
Seah I, Agrawal R. Can the Coronavirus disease 2019 (COVID-19) affect the eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals. Oc Immunol Inflam. 2020;28:391-5.
Van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. New Engl J Med. 2020;382:1564-7.
Awadasseid A, Wu Y, Tanaka Y, Zhang W. Initial success in the identification and management of the coronavirus disease 2019 (COVID-19) indicates human-to-human transmission in Wuhan, China. Internat J Biol Sci. 2020;16:1846-60.
Chen L, Liu M, Zhang Z, Qiao K, Huang T, Chen M, et al. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. Brit J Ophthalmol. 2020;104:748-51.
Dong X, Cao Y, Lu X, Zhang J, Du H, Yan Y, et al. Eleven faces of coronavirus disease 2019. Allergy; 2020 [acceso: 04/06/2020]. Disponible en: https://onlinelibrary.wiley.com/doi/full/10.1111/all.14289
Wan KH, Huang SS, Young AL, Lam DSC. Precautionary measures needed for ophthalmologists during pandemic of the coronavirus disease 2019 (COVID-19). Acta Ophthalmol. 2020;98:221-2.
Qing H, Li Z, Yang Z, Shi M, Huang Z, Song J, et al. The possibility of COVID-19 transmission from eye to nose. Acta Ophthalmol. 2020;98:200.
Liang L, Wu P. There may be virus in conjunctival secretion of patients with COVID-19. Acta Ophthalmol. 2020;98:223.
Jørstad ØK, Moe MC, Eriksen K, Petrovski G, Bragadóttir R. Coronavirus disease 2019 (COVID-19) outbreak at the Department of Ophthalmology, Oslo University Hospital, Norway. Acta Ophthalmol. 2020;98:388-9.
Jin H, Hong C, Chen S, Zhou Y, Wang Y, Mao L, et al. Consensus for prevention and management of coronavirus disease 2019 (COVID-19) for neurologists. Stroke Vasc Neurol. 2020;23(Supl. 1):15.
Lai THT, Tang EWH, Chau SKY, Li KKW. Reply to ocular manifestation, eye protection and COVID-19. Graef Arch Clin Experim Ophthalmol. 2020;258:1341.
MINSAP. Protocolo Nacional MINSAP vs. COVID-19. La Habana: MINSAP; 2020:1-103.
Wu P, Duan F, Luo C, Liu Q, Qu X, Liang L, et al. Characteristics of ocular findings of patients with Coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020;138:575.
Minocha A, Sim SY, Than J, Vakros G. Survey of ophthalmology practitioners in A&E on current COVID-19 guidance at three Major UK Eye Hospitals. Eye; 2020. p. 1-3.
Romano MR, Montericcio A, Montalbano C, Raimondi R, Allegrini D, Ricciardelli G, et al. Facing COVID-19 in Ophthalmology Department. Curr Eye Res. 2020;45:653-8.
Conti P. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by COVID-19: antiinflammatory strategies. J Biol Regul Homeost Agen. 2020;34:1.
Chen MJ, Chang KJ, Hsu CC, Lin PY, Liu CJL. Precaution and prevention of Coronavirus disease 2019 (COVID-19) infection in the eye. Journal of the Chinese Medical Association; 2020 [acceso: 04/06/2020]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202097/
Renu K, Prasanna PL, Valsala Gopalakrishnan A. Coronaviruses pathogenesis, comorbidities and multi-organ damage. Lif Sci. 2020;255:117839.